Page results
- 
                                    
                                                                            
Patient information for patients dealing with difficult feelings. This information will give you useful advice about what to do if you find yourself in a crisis.
 - 
                                    
                                                                            
Postnatal care should be a continuation of the care the woman has received through her pregnancy, labour and birth and take into account the woman’s individual needs and preferences.
 - 
                                    
                                                                            
This is a step-by-step guide on how to examine your testicles. It explains what you need to do and why it’s important.
 - 
                                    
                                                                            
Patient information by Respiratory Outpatient Physiotherapy regarding the treatment and management of your cough.
 - 
                                    
                                                                            
Information and advice for patients, relatives and carers about thoracic surgery.
 - 
                                    
                                                                            
Find and Treat screen tens of thousands of the most vulnerable, homeless and high-risk people every year using mobile units deployed from UCLH.
 - 
                                    
                                                                            
The special haematology service provides a comprehensive investigation of haemolytic amaemia, haemoglobinopathies and red cell enzymopathy.
 - 
                                    
                                                                            
Parenteral Nutrition, also know as PN, is used to feed extremely premature or unwell babies.
 - 
                                    
                                                                            
This page has been written for patients who have been recommended hormone therapy for prostate cancer. It explains what the treatment involves, describes side-effects you may experience, and how best to cope with them.
 - 
                                    
                                                                            
Contractual screening for NGOs, Governmental organisations, academic institutions and private companies. Pre-assignment health reviews for medical fitness to travel
 
File results
- 
                                                                            
FOI/2022/0546 - Metastatic Cholangiocarcinoma (CCA) or Acute myeloid leukaemia
 - 
                                                                            
FOI/2022/0548 - Biologic and biosimilar products within Rheumatology
 - 
                                                                            
FOI/2022/0549 - SACT (systemic anti-cancer therapy) /cervical cancer treatments
 - 
                                                                            
FOI/2022/0550 - Patients that have been treated for glioblastoma brain cancer
 - 
                                                                            
FOI/2022/0553 - Patients tested for non-small cell lung cancer biomarkers
 - 
                                                                            
FOI/2022/0561 - Regulation (EU) 2016/425 Declarations of Conformity for all type IIR surgical masks provided as PPE to staff
 - 
                                                                            
FOI/2022/0571 - Treatment for biologic medicines in Dermatology
 - 
                                                                            
FOI/2022/0572 - Treatments for Hidradenitis Suppurativa and Psoriasis
 - 
                                                                            
FOI/2022/0573 - Use of WhatsApp by or within the Trust
 - 
                                                                            
FOI/2022/0513 - Myelofibrosis treatment